Covington Reps Bristol-Myers In $325M Amira Buy

Law360, New York (July 22, 2011, 8:04 PM EDT) -- Bristol-Myers Squibb Co. announced Thursday that it will pay $325 million in cash to buy Amira Pharmaceuticals Inc., a small-molecule pharmaceutical company focused on making new drugs to treat inflammatory and fibrotic diseases.

New York-based Bristol-Myers will acquire all of the outstanding shares in the privately held Amira, it said. Apart from the upfront payment, the deal includes potential future milestone payments that could total $150 million, the company said.

The purchase gives the pharmaceutical giant control of California-based Amira's fibrosis program, including a prototype drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.